Informa Connect

3 days ago | informaconnect.com | Brandy Fidler

In a recent webinar, industry experts shared insights on how digital patient engagement strategies are transforming patient support programs. The presentation, featuring Oliver Dunford, vice president of life sciences at Relay Network, and Angela Cornacchia, director of patient experience, patient access services, at Alkermes, revealed data from over 500,000 patient interactions across 26 specialty and rare disease brands.

4 days ago | informaconnect.com | Brandy Fidler

A survey by specialty pharmacy Lumicera Health Services, a subsidiary of Navitus Health Solutions, has uncovered a disconnect between Americans’ concerns about prescription costs and their willingness to seek help about it from pharmacists. The research, conducted in February of 2,000 adults in the US, showed that while most Americans trust their pharmacists, they rarely engage them in conversations about medication affordability.

5 days ago | informaconnect.com | Brandy Fidler

In a sit-down interview at the Pharmaceutical Compliance Congress, Tim Stow, global head of ethics and compliance at Galderma, spoke with Compliance Insider about his extensive experience in the pharmaceutical industry and his current leadership role. Stow brings over 30 years of experience in the life sciences sector to his current position. A lawyer by training, he has built a career trajectory working with numerous healthcare companies around the world.

1 week ago | informaconnect.com | Brandy Fidler

In a recent webinar, industry leaders discussed applications, challenges, and strategies for implementing AI in compliance programs.

1 week ago | informaconnect.com | Gareth Macdonald

A pilot program that helped community sites take part in drug studies has been set up as a nonprofit organization in a bid to expand its network across the US. The Clinical Trials Access Collaborative (CTAC) — which launched last week — was developed by Yale School of Medicine researchers looking to partner with community sites to increase diversity in clinical trials.